GENERAL MILLS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GENERAL MILLS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | May 26, 2024 | $2.04B | Jun 26, 2024 |
| FY2024 | May 28, 2023 | $1.96B | Jun 26, 2024 |
| FY2024 | May 29, 2022 | $2.13B | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $2.19B | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $2.05B | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $2.04B | Jun 30, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $4.56B | Jun 26, 2025 |
| FY2025 | Feb 23, 2025 | $4.84B | Jun 26, 2025 |
| FY2025 | Nov 24, 2024 | $5.24B | Jun 26, 2025 |
| FY2025 | Aug 25, 2024 | $4.85B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $4.71B | Jun 26, 2025 |
| FY2025 | Feb 25, 2024 | $5.10B | Jun 26, 2025 |
| FY2025 | Nov 26, 2023 | $5.14B | Jun 26, 2025 |
| FY2025 | Aug 27, 2023 | $4.90B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $5.03B | Jun 26, 2024 |
| FY2024 | Feb 26, 2023 | $5.13B | Jun 26, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $1.47B | Jun 26, 2025 |
| FY2025 | Feb 23, 2025 | $1.64B | Jun 26, 2025 |
| FY2025 | Nov 24, 2024 | $1.93B | Jun 26, 2025 |
| FY2025 | Aug 25, 2024 | $1.69B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $1.69B | Jun 26, 2025 |
| FY2025 | Feb 25, 2024 | $1.71B | Jun 26, 2025 |
| FY2025 | Nov 26, 2023 | $1.77B | Jun 26, 2025 |
| FY2025 | Aug 27, 2023 | $1.77B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $1.73B | Jun 26, 2024 |
| FY2024 | Feb 26, 2023 | $1.66B | Jun 26, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $294.00M | Jun 26, 2025 |
| FY2025 | Feb 23, 2025 | $625.60M | Jun 26, 2025 |
| FY2025 | Nov 24, 2024 | $795.70M | Jun 26, 2025 |
| FY2025 | Aug 25, 2024 | $579.90M | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $557.50M | Jun 26, 2025 |
| FY2025 | Feb 25, 2024 | $670.10M | Jun 26, 2025 |
| FY2025 | Nov 26, 2023 | $595.50M | Jun 26, 2025 |
| FY2025 | Aug 27, 2023 | $673.50M | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $614.90M | Jun 26, 2024 |
| FY2024 | Feb 26, 2023 | $553.10M | Jun 26, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $3.30B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $3.43B | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $3.43B | Jun 26, 2025 |
| FY2024 | May 29, 2022 | $3.48B | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $3.14B | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $2.95B | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $2.52B | Jun 30, 2021 |
| FY2020 | May 27, 2018 | $2.42B | Jul 2, 2020 |
| FY2019 | May 28, 2017 | $2.49B | Jun 28, 2019 |
| FY2018 | May 29, 2016 | $2.71B | Jun 29, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $256.60M | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $257.80M | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $257.60M | Jun 26, 2025 |
| FY2024 | May 29, 2022 | $243.10M | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $239.30M | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $224.40M | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $221.90M | Jun 30, 2021 |
| FY2020 | May 27, 2018 | $219.10M | Jul 2, 2020 |
| FY2019 | May 28, 2017 | $218.20M | Jun 28, 2019 |
| FY2018 | May 29, 2016 | $222.10M | Jun 29, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $3.45B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $3.26B | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $3.50B | Jun 26, 2025 |
| FY2024 | May 29, 2022 | $3.15B | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $3.08B | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $3.15B | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $2.94B | Jun 30, 2021 |
| FY2020 | May 27, 2018 | $2.85B | Jul 2, 2020 |
| FY2019 | May 28, 2017 | $2.89B | Jun 28, 2019 |
| FY2018 | May 29, 2016 | $3.12B | Jun 29, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $2.92B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $3.30B | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $2.78B | Jun 26, 2025 |
| FY2024 | May 29, 2022 | $3.32B | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $2.98B | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $3.68B | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $2.81B | Jun 30, 2021 |
| FY2020 | May 27, 2018 | $2.84B | Jul 2, 2020 |
| FY2019 | May 28, 2017 | $2.42B | Jun 28, 2019 |
| FY2018 | May 29, 2016 | $2.76B | Jun 29, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $625.30M | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $774.10M | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $689.50M | Jun 26, 2025 |
| FY2024 | May 29, 2022 | $568.70M | Jun 26, 2024 |
| FY2023 | May 30, 2021 | $530.80M | Jun 28, 2023 |
| FY2022 | May 31, 2020 | $460.80M | Jun 30, 2022 |
| FY2021 | May 26, 2019 | $537.60M | Jun 30, 2021 |
| FY2020 | May 27, 2018 | $622.70M | Jul 2, 2020 |
| FY2019 | May 28, 2017 | $684.40M | Jun 28, 2019 |
| FY2018 | May 29, 2016 | $729.30M | Jun 29, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $33.07B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $31.47B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $31.45B | Jun 26, 2024 |
| FY2023 | May 29, 2022 | $31.09B | Jun 28, 2023 |
| FY2022 | May 30, 2021 | $31.84B | Jun 30, 2022 |
| FY2021 | May 31, 2020 | $30.81B | Jun 30, 2021 |
| FY2020 | May 26, 2019 | $30.11B | Jul 2, 2020 |
| FY2019 | May 27, 2018 | $30.62B | Jun 28, 2019 |
| FY2018 | May 28, 2017 | $21.81B | Jun 29, 2018 |
| FY2017 | May 29, 2016 | $21.71B | Jun 29, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $23.86B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $21.82B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $20.75B | Jun 26, 2024 |
| FY2023 | May 29, 2022 | $20.30B | Jun 28, 2023 |
| FY2022 | May 30, 2021 | $21.46B | Jun 30, 2022 |
| FY2021 | May 31, 2020 | $21.91B | Jun 30, 2021 |
| FY2020 | May 26, 2019 | $22.19B | Jul 2, 2020 |
| FY2019 | May 27, 2018 | $23.36B | Jun 28, 2019 |
| FY2018 | May 28, 2017 | $16.22B | Jun 29, 2018 |
| FY2017 | May 29, 2016 | $15.56B | Jun 29, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $9.20B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $9.40B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $10.45B | Jun 26, 2024 |
| FY2023 | May 29, 2022 | $10.54B | Jun 28, 2023 |
| FY2022 | May 30, 2021 | $9.47B | Jun 30, 2022 |
| FY2021 | May 31, 2020 | $8.06B | Jun 30, 2021 |
| FY2020 | May 26, 2019 | $7.05B | Jul 2, 2020 |
| FY2019 | May 27, 2018 | $6.14B | Jun 28, 2019 |
| FY2018 | May 28, 2017 | $4.33B | Jun 29, 2018 |
| FY2017 | May 29, 2016 | $4.93B | Jun 29, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $15.62B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $14.75B | Jun 26, 2025 |
| FY2025 | May 28, 2023 | $14.51B | Jun 26, 2025 |
| FY2025 | May 29, 2022 | $14.38B | Jun 26, 2025 |
| FY2024 | May 30, 2021 | $14.06B | Jun 26, 2024 |
| FY2023 | May 31, 2020 | $13.92B | Jun 28, 2023 |
| FY2022 | May 26, 2019 | $14.00B | Jun 30, 2022 |
| FY2021 | May 27, 2018 | $14.07B | Jun 30, 2021 |
| FY2020 | May 28, 2017 | $8.75B | Jul 2, 2020 |
| FY2019 | May 29, 2016 | $8.74B | Jun 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $21.92B | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $20.97B | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $19.84B | Jun 26, 2024 |
| FY2023 | May 29, 2022 | $18.53B | Jun 28, 2023 |
| FY2022 | May 30, 2021 | $17.07B | Jun 30, 2022 |
| FY2021 | May 31, 2020 | $15.98B | Jun 30, 2021 |
| FY2020 | May 26, 2019 | $15.00B | Jul 2, 2020 |
| FY2019 | May 27, 2018 | $14.46B | Jun 28, 2019 |
| FY2018 | May 28, 2017 | $13.14B | Jun 29, 2018 |
| FY2017 | May 29, 2016 | $12.62B | Jun 29, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $363.90M | Jun 26, 2025 |
| FY2025 | May 26, 2024 | $418.00M | Jun 26, 2025 |
| FY2024 | May 28, 2023 | $585.50M | Jun 26, 2024 |
| FY2023 | May 29, 2022 | $569.40M | Jun 28, 2023 |
| FY2022 | May 30, 2021 | $1.51B | Jun 30, 2022 |
| FY2021 | May 31, 2020 | $1.68B | Jun 30, 2021 |
| FY2021 | May 26, 2019 | $450.00M | Jun 30, 2021 |
| FY2021 | May 27, 2018 | $399.00M | Jun 30, 2021 |
| FY2020 | May 28, 2017 | $766.10M | Jul 2, 2020 |
| FY2020 | May 29, 2016 | $766.10M | Jul 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | May 29, 2011 | $6.57B | Jul 8, 2011 |
| FY2011 | May 30, 2010 | $5.38B | Jul 8, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | 0 | Jun 26, 2025 |
| FY2025 | Feb 23, 2025 | 1 | Jun 26, 2025 |
| FY2025 | Nov 24, 2024 | 1 | Jun 26, 2025 |
| FY2025 | Aug 25, 2024 | 1 | Jun 26, 2025 |
| FY2025 | May 26, 2024 | 0 | Jun 26, 2025 |
| FY2025 | Feb 25, 2024 | 1 | Jun 26, 2025 |
| FY2025 | Nov 26, 2023 | 1 | Jun 26, 2025 |
| FY2025 | Aug 27, 2023 | 1 | Jun 26, 2025 |
| FY2024 | May 28, 2023 | 1 | Jun 26, 2024 |
| FY2024 | Feb 26, 2023 | 0 | Jun 26, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | 0 | Jun 26, 2025 |
| FY2025 | Feb 23, 2025 | 1 | Jun 26, 2025 |
| FY2025 | Nov 24, 2024 | 1 | Jun 26, 2025 |
| FY2025 | Aug 25, 2024 | 1 | Jun 26, 2025 |
| FY2025 | May 26, 2024 | 0 | Jun 26, 2025 |
| FY2025 | Feb 25, 2024 | 1 | Jun 26, 2025 |
| FY2025 | Nov 26, 2023 | 1 | Jun 26, 2025 |
| FY2025 | Aug 27, 2023 | 1 | Jun 26, 2025 |
| FY2024 | May 28, 2023 | 1 | Jun 26, 2024 |
| FY2024 | Feb 26, 2023 | 0 | Jun 26, 2024 |